Advertisement CMC Biologics names new CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

CMC Biologics names new CEO

CMC Biologics, a provider of fully integrated biopharmaceutical development and manufacturing services, has named Claes Glassell as the new CEO.

Glassell joined the CMC Biologics board of directors in 2005.

Most recently, Glassell worked as CEO of Cerus Corporation and prior to that as president of Cambrex Corp.

CMC Biologics CEO Mads Laustsen said as one of the founders of CMC Claes brings the best skills and experience to ensure CMC’s continued growth.